Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| diPaRIS: Dynamic and Interpretable Protein-RNA Interactions Prediction With U-Shaped Network and Novel Structure Encoding. | Adv Sci (Weinh) | 2025 | 40883253 | PubTator, text mining | PubMed |
| Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteostatic Collapse, and Network Failure Across the CNS. | Biomedicines | 2025 | 40868276 | PubTator, text mining | PubMed |
| METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. | Int J Biol Sci | 2025 | 40860196 | PubTator, text mining | PubMed |
| Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. | Clin Epigenetics | 2025 | 40851017 | PubTator, text mining | PubMed |
| Clinical and prognostic significance of m6A hypomethylation and IGF2BP3 overexpression in gastric cancer: an integrated epigenomic-transcriptomic analysis. | Hum Genomics | 2025 | 40847370 | PubTator, text mining | PubMed |
| IGF2BP1-mediated methylation of ABCA1 facilitates tumor progression by affecting cholesterol metabolism in lung adenocarcinoma. | Amino Acids | 2025 | 40844715 | PubTator, text mining | PubMed |
| Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis. | FASEB J | 2025 | 40838537 | PubTator, text mining | PubMed |
| Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. | Cell Death Discov | 2025 | 40830264 | PubTator, text mining | PubMed |
| Cucurbitacin B in cancer: A comprehensive review of its targets and molecular mechanisms. | Biochem Pharmacol | 2025 | 40818548 | PubTator, text mining | PubMed |
| CircRNAs: functions and emerging roles in cancer and immunotherapy. | BMC Med | 2025 | 40817061 | PubTator, text mining | PubMed |
| Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors. | J Med Chem | 2025 | 40815386 | PubTator, text mining | PubMed |
| CircRNA Profiles Analysis of Neuroblastoma for Identification of Drug Targets. | IEEE Trans Comput Biol Bioinform | 2025 | 40811419 | PubTator, text mining | PubMed |
| Regulation of Subcellular Protein Synthesis for Restoring Neural Connectivity. | Int J Mol Sci | 2025 | 40806415 | PubTator, text mining | PubMed |
| Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review. | Eur J Med Res | 2025 | 40804731 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. | J Transl Med | 2025 | 40804394 | PubTator, text mining | PubMed |
| GGCRB: A Graph Neural Network Approach for Predicting CircRNA-RBP Interactions Using Structural and Sequence Features. | ACS Omega | 2025 | 40787315 | PubTator, text mining | PubMed |
| Mechanism of METTL14 regulates HBV-HCC malignant progression by mediating m6A modification of FOXP3 and thus transcriptional activation of ALDOB. | J Mol Histol | 2025 | 40778958 | PubTator, text mining | PubMed |
| Hyperactivation of the m6A demethylase FTO to down-regulate SLC7A11/xCT-mediated redox homeostasis and epigenetic remodeling in facial infiltrating lipomatosis. | Free Radic Biol Med | 2025 | 40769313 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization. | Cell Biol Toxicol | 2025 | 40760370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=9